Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2022 Sep 26;12:16052. doi: 10.1038/s41598-022-20899-w

Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease

Manaf AlQahtani 1,2,3,, Nitya Kumar 3, Dhuha Aljawder 4, Abdulkarim Abdulrahman 1,5, Mohammed Wael Mohamed 6, Fatema Alnashaba 4, Mohammed Abu Fayyad 3, Faisal Alshaikh 2, Fatima Alsahaf 4, Sawsan Saeed 3, Amal Almahroos 4, Zainab Abdulrahim 4, Sameer Otoom 3, Stephen L Atkin 3
PMCID: PMC9512917  PMID: 36163461

Correction to: Scientific Reports 10.1038/s41598-022-08794-w, published online 23 March 2022

Mohammed Wael Mohamed was omitted from the author list in the original version of this Article.

The Author Contributions section now reads:

“N.K.: data analysis, interpretation and preparation of the manuscript; D.A., A.A., F.A., M.A.F., F.A., F.A., S.S., A.A., Z.A., S.O. S.A. & M.M.: conception and design, data collection, manuscript review; S.S., N.K. & S.L.A.: writing and manuscript review; M.A.Q.: conception and design of the study and manuscript review.”

The original Article has been corrected.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES